Are estrogen receptors alpha detectable in normal and abnormal thyroid tissue?

European Archives of Oto-Rhino-Laryngology

Volumn 267, Issue 11, 2010, Pages 1753-1757

  Vaiman, Michael ^a   Olevson, Youlian ^a   Sandbank, Judith ^a   Habler, Liliana ^a   Zehavi, Sergei ^a   Kessler, Alex ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Carcinomas; Estrogen receptors; Immunoreactivity; Thyroid gland

Indexed keywords

ESTROGEN RECEPTOR ALPHA;

ADULT; ARTICLE; BREAST CANCER; CONTROLLED STUDY; CYTOPLASM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REFERENCE VALUE; THYROID GLAND; THYROID TUMOR; METABOLISM; PATHOLOGY; THYROIDECTOMY;

ADULT; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; THYROID GLAND; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 79952202626     PISSN: 09374477     EISSN: 14344726     Source Type: Journal    
DOI: 10.1007/s00405-010-1269-0     Document Type: Article

References (29)

1. Miki H, Oshimi K, Mrimoto T, Monden Y (1990) Sex hormone receptors in human thyroid tissues. Cancer 66:1759-1762
2. Henderson BE, Ross RK, Pike MC, Casagrande JT (1982) Endogenous hormones as a major factor in human cancer. Cancer Res 42:3232-3239
3. Samaan NA, Maheshwari YK, Nader S et al (1983) Impact of therapy for differentiated carcinoma of the thyroid. J Clin Endocrinol Metab 56:1136-1138
4. Lewy-Trenda I (2002) Estrogen and progesterone receptors in neoplastic and non neoplastic thyroid lesions. Pol J Pathol 53:67-72
5. Greene GL, Nolan C, Engler JP, Jensen EV (1980) Monoclonal antibodies to human estrogen receptor. Proc Natl Acad Sci USA 77(9):5115-5119
6. Garancis JC, Miller LS, Tomita JT, Tieu TM, Clowry LJ Jr (1983) Immunoperoxidase localization of estrogen receptors in human breast carcinoma. Cancer Detect Prev 6(1-2):235-239
7. Gilbert C (1997) Major human cancers are preventable: physiological stimuli induce a dopamine-thyroid-immune efficient mechanism. Eur J Cancer Prev 6(3):269-276
8. Sonoo H, Kurebayashi J (2001) Endocrine therapy for advanced or recurrent breast cancer. Gan To Kagaku Ryoho 28(7):909-916
9. Mosselman S, Polman J, Dijkema R (1996) ERb: Identification and characterization of a novel human estrogen receptor. FEBS Lett 392(1):49-53
10. van Hoeven KH, Menendez-Botet CJ, Strong EW, Huvos AG (1993) Estrogen and progesterone receptor content in human thyroid disease. Am J Clin Pathol 99(2):175-181
11. Hiasa Y, Nishioka H, Kitahori Y et al (1993) Immunohisto-chemical analysis of estrogen receptors in 313 paraffin section cases of human thyroid tissue. Oncology 50(2):132-136
12. Yane K, Kitahori Y, Konishi N et al (1994) Expression of estrogen receptor in human thyroid neoplasm. Cancer Lett 84:59-66
13. Giani C, Campani D, De Negri F et al (1993) Interference of thyroperoxidase on immuno-cytochemical determination of steroid receptors in thyroid tissue. J Endocrinol Invest 16(1):37-43
14. Candanedo-Gonzalez FA, Gamboa-Dominguez A (2007) Post-menopause is associated with recurrence of differentiated papillary thyroid carcinoma. Med Hypotheses 69(1):209-213
15. Diaz NM, Mazoujian G, Wick MR (1991) Estrogen-receptor protein in thyroid neoplasms. An Immunohistochemical analysis of papillary carcinoma, follicular carcinoma, and follicular adenoma. Arch Pathol Lab Med 115(12):1203-1207
16. Katoh AK, Stemmler N, Specht S, D'Amico F (1997) Immunop-eroxidase staining for estrogen and progesterone receptors in archival formalin fixed, paraffin embedded breast carcinomas after microwave antigen retrieval. Biotech Histochem 72(6):291-298
17. Stoss F, Spona J (1987) Steroid hormone receptors in struma. Wien Klin Wochenschr 99(13):460-461
18. Hampl R, Němec J, Heresová J, Kimlová I, Stárka L (1985) Estrogen receptors in human goitrous and neoplastic thyroid. Endocrinol Exp 19(4):227-230
19. Kawabata W, Suzuki T, Moriya T, Fujimori K et al (2003) Estrogen receptors (a and b) and 17b-hydroxysteroid dehydro-genase type 1 and 2 in thyroid disorders: possible in situ estrogen synthesis and action. Mod Pathol 16:437-444
20. Zeng Q, Chen G, Vlantis A, Tse G, van Hasselt C (2008) The contributions of oestrogen receptor isoforms to the development of papillary and anaplastic thyroid carcinomas. J Pathol 214(4): 425-433
21. Cho MA, Lee MK, Nam KH, Chung WY et al (2007) Expression and role of estrogen receptor alpha and beta in medullary thyroid carcinoma: different roles in cancer growth and apoptosis. J Endocrinol 195(2):255-263
22. Ceresini G, Morganti S, Graiani V et al (2006) Estrogen receptors (ER)-B but not ER-A is present in thyroid vessels: immunohis-tochemical evaluation in multinodular goiter and papillary thyroid carcinoma. Thyroid 6:1215-1220
23. Bléchet C, Lecomte P, De Calan L et al (2007) Expression of sex steroid hormone receptors in C cell hyperplasia and medullary thyroid carcinoma. Virchows Arch 450(4):433-439
24. Kurzon RM, Sternberger LA (1978) Estrogen receptor immuno-cytochemistry. J Histochem Cytochem 26(10):803-808
25. Pertschuk LP, Gaetjens E, Carter AC et al (1979) An improved histochemical method for detection of estrogen receptors in mammary cancer. Comparison with biochemical assay. Am J Clin Pathol 71(5):504-508
26. Goulding H, Pinder S, Cannon P et al (1995) A new immuno-histochemical antibody for the assessment of estrogen receptor status on routine formalin-fixed tissue samples. Hum Pathol 26(3):291-294
27. Harvey JM, Clark GM, Osborne CK, Allred DC (1999) Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 17(5):1474-1481
28. Rhodes A, Jasani B, Barnes DM et al (2000) Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: interlaboratory variance in the sensitivity of detection and evaluation of scoring systems. J Clin Pathol 53(2):125-130
29. Huang Z, Zhu W, Szekeres G, Xia H (2005) Development of new rabbit monoclonal antibody to estrogen receptor: immunohisto-chemical assessment on formalin-fixed, paraffin-embedded tissue sections. Appl Immunohistochem Mol Morphol 13(1):91-95